A key event in the regulation of eukaryotic gene expression is the post-translational modification of nucleosomal histones, which converts regions of chromosomes into transcriptionally active or inactive chromatin. The most common post-translational modification of histones is the acetylation of ? amino groups on conserved lysine residues in the histones' amino-terminal tail domains. Hyperacetylation of histones generally correlates with transcriptionally active chromatin, perhaps by increasing the accessibility of nucleosomal DNA to transcription factors, while hypoacetylation of histones correlates with transcriptional silencing. In addition to its effect on transcription, acetylation/deacetylation of histones may have important roles in many cellular processes including chromatin assembly, DNA replication and repair, recombination, and chromosome segregation. Swift and significant advances have been made in the last several years toward understanding histone acetylation and deacetylation. Currently, there are over twenty histone acetyltransferases identified and nearly the same number of cloned human histone deacetylase (HDAC) enzymes. In this proposal, the overall hypothesis is that HDACs play a pivotal role in gene regulation. The long-term goal of this project is aimed at obtaining a greater mechanistic understanding of how HDACs regulate gene expression. Particular emphasis will be devoted to a detailed molecular dissection of the human HDAC3 and HDAC4 enzymes, and the elucidation of the molecular mechanisms by which HDAC inhibitors alter gene transcription. These studies will ultimately provide important insights critical for a thorough understanding of the intricate mechanisms operating to orchestrate gene expression in mammalian cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM058486-08
Application #
6998941
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Carter, Anthony D
Project Start
1999-01-01
Project End
2007-07-31
Budget Start
2006-01-01
Budget End
2007-07-31
Support Year
8
Fiscal Year
2006
Total Cost
$354,948
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Yuan, Zhigang; Zhang, Xiaohong; Sengupta, Nilanjan et al. (2007) SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell 27:149-62
Zhang, Xiaohong; Yuan, Zhigang; Zhang, Yingtao et al. (2007) HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell 27:197-213
Lee, Heehyoung; Sengupta, Nilanjan; Villagra, Alejandro et al. (2006) Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation. Mol Cell Biol 26:5259-69
Baumeister, Peter; Luo, Shengzhan; Skarnes, William C et al. (2005) Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol Cell Biol 25:4529-40
Zhang, Xiaohong; Ozawa, Yukiyasu; Lee, Heehyoung et al. (2005) Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev 19:827-39
Sengupta, Nilanjan; Seto, Edward (2004) Regulation of histone deacetylase activities. J Cell Biochem 93:57-67
Zhang, Xiaohong; Wharton, Walker; Yuan, Zhigang et al. (2004) Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. Mol Cell Biol 24:5106-18
Lee, Heehyoung; Rezai-Zadeh, Natalie; Seto, Edward (2004) Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Mol Cell Biol 24:765-73
Rezai-Zadeh, Natalie; Tsai, Shih-Chang; Wen, Yu-Der et al. (2004) Histone deacetylases: purification of the enzymes, substrates, and assay conditions. Methods Enzymol 377:167-79
Kapustin, Galina V; Fejer, Gyorgy; Gronlund, Jennifer L et al. (2003) Phosphorus-based SAHA analogues as histone deacetylase inhibitors. Org Lett 5:3053-6

Showing the most recent 10 out of 19 publications